Evotec AG Stock
Evotec AG took a tumble today and lost -€1.000 (-3.790%).
The stock is one of the favorites of our community with 29 Buy predictions and 3 Sell predictions.
As a result the target price of €37.00 shows a positive potential of 25.212% compared to the current price of €29.55 for Evotec AG.
For the coming years our community has positive and negative things to say abot the Evotec AG stock. Criterium "Revenue growth" gathered the most positive votes but regarding "Unique positioning" there were negative voices in the community.
The stock is one of the favorites of our community with 29 Buy predictions and 3 Sell predictions.
As a result the target price of €37.00 shows a positive potential of 25.212% compared to the current price of €29.55 for Evotec AG.
For the coming years our community has positive and negative things to say abot the Evotec AG stock. Criterium "Revenue growth" gathered the most positive votes but regarding "Unique positioning" there were negative voices in the community.
Pros and Cons of Evotec AG in the next few years
Pros
4
Revenue growth >5% per year expected
3
Medium risks for its business
3
Fair valuation
Cons
1
Few uniques
1
Risky balance sheet
Performance of Evotec AG vs. its peers
Security | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Evotec AG | -3.790% | -8.030% | -10.940% | 35.055% | -1.958% | 106.643% | 803.946% |
MorphoSys AG | 1.060% | -1.750% | -15.331% | -17.086% | -12.641% | 3.224% | 97.646% |
Nektar Therapeutics | -3.640% | -0.415% | 11.804% | 7.452% | 26.000% | - | - |
Ionis Pharmaceuticals Inc. | 3.120% | 2.062% | -11.322% | -6.954% | -4.835% | 3.772% | 16.399% |
Comments
Buy Evotec AG
Sell Evotec AG
Buy Evotec AG
Other discussions about Evotec AG Stock
Trading Evotec AG
Trading Evotec AG
News

DGAP-News: EVOTEC AND RAPPTA THERAPEUTICS ENTER DISCOVERY AND DEVELOPMENT PARTNERSHIP FOCUSED ON ONCOLOGY TARGET
DGAP-News: EVOTEC AND RAPPTA THERAPEUTICS ENTER DISCOVERY AND DEVELOPMENT PARTNERSHIP FOCUSED ON ONCOLOGY TARGET

DGAP-News: EVOTEC PRESENTS GROWTH DRIVERS OF 'AUTOBAHN TO CURES' AT CAPITAL MARKETS DAY
DGAP-News: EVOTEC PRESENTS GROWTH DRIVERS OF 'AUTOBAHN TO CURES' AT CAPITAL MARKETS DAY

DGAP-News: EVOTEC AND STORM THERAPEUTICS LEVERAGE INDIGO PLATFORM TO PROGRESS ONCOLOGY PROJECT TOWARDS CLINICAL STUDIES
DGAP-News: EVOTEC AND STORM THERAPEUTICS LEVERAGE INDIGO PLATFORM TO PROGRESS ONCOLOGY PROJECT TOWARDS CLINICAL STUDIES